Rezolute, Inc. financial data

Symbol
RZLT on Nasdaq
Industry
Pharmaceutical Preparations
Location
275 Shoreline Drive, Suite 500, Redwood City, CA
State of incorporation
NV
Fiscal year end
June 30
Former names
AntriaBio, Inc. (to 12/7/2017), FITS MY STYLE INC (to 1/11/2013)
Latest financial report
10-K - Q2 2024 - Sep 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.29K % -54%
Debt-to-equity 12.5 % +156%
Return On Equity -70.7 % -83.7%
Return On Assets -62.9 % -71.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.4M shares +50.3%
Common Stock, Shares, Outstanding 53.2M shares +44.6%
Entity Public Float 33.3M USD -47.7%
Common Stock, Value, Issued 53K USD +43.2%
Weighted Average Number of Shares Outstanding, Basic 51.5M shares +0.54%
Weighted Average Number of Shares Outstanding, Diluted 51.5M shares +0.54%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 55.7M USD +27.2%
General and Administrative Expense 14.7M USD +20.6%
Operating Income (Loss) -70.4M USD -25.8%
Nonoperating Income (Expense) 1.96M USD -53.3%
Net Income (Loss) Attributable to Parent -68.5M USD -32.2%
Earnings Per Share, Basic -1.33 USD/shares -31.7%
Earnings Per Share, Diluted -1.33 USD/shares -31.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 70.4M USD +339%
Marketable Securities, Current 56.5M USD -34.2%
Assets, Current 129M USD +22.6%
Property, Plant and Equipment, Net 103K USD -25.9%
Operating Lease, Right-of-Use Asset 1.88M USD -8.47%
Assets 133M USD +7.29%
Accounts Payable, Current 4.9M USD +49.9%
Employee-related Liabilities, Current 1.81M USD +105%
Liabilities, Current 9.61M USD +84.7%
Operating Lease, Liability, Noncurrent 1.66M USD -14.3%
Liabilities 11.7M USD +55.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -79K USD +77.5%
Retained Earnings (Accumulated Deficit) -329M USD -26.2%
Stockholders' Equity Attributable to Parent 121M USD +4.16%
Liabilities and Equity 133M USD +7.29%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.6M USD -39.5%
Net Cash Provided by (Used in) Financing Activities 11.6M USD +347%
Net Cash Provided by (Used in) Investing Activities 2.61M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 53.2M shares +44.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.98M USD -304%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 70.4M USD +339%
Deferred Tax Assets, Valuation Allowance 69.8M USD +17.9%
Deferred Tax Assets, Gross 70.3M USD +17.6%
Operating Lease, Liability 2.23M USD -10.1%
Payments to Acquire Property, Plant, and Equipment 70K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -68.2M USD -30.8%
Lessee, Operating Lease, Liability, to be Paid 2.49M USD -12.6%
Property, Plant and Equipment, Gross 210K USD 0%
Operating Lease, Liability, Current 568K USD +4.99%
Lessee, Operating Lease, Liability, to be Paid, Year Two 770K USD +22.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 748K USD +8.56%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 264K USD -29.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 750K USD +16.1%
Deferred Tax Assets, Operating Loss Carryforwards 38.9M USD -3.94%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 400K shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 666K USD
Operating Lease, Payments 171K USD +490%
Additional Paid in Capital 450M USD +19.3%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 526K USD -8.52%
Share-based Payment Arrangement, Expense 7.36M USD +1.27%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%